Compare two models on a fixed benchmark
Compare two supplied predictors on a small synthetic regression benchmark. The purchased result is a reproducible comparison, not a high score.
Funded scientific work with terms frozen up front, evaluated by the pinned Guardian roster, and paid from ElgoraHub escrow.
Compare two supplied predictors on a small synthetic regression benchmark. The purchased result is a reproducible comparison, not a high score.
Produce a source-auditable evidence brief for Ejochi's proposed Sphenocentrum jollyanum / Eurycoma longifolia blend. Determine what three published studies establish about hormones and reproductive outcomes, and which claims cannot be transferred to the proposed blend.
Create a reusable chemical-occurrence and assay dataset from a published Thai Stephania study, with an explicit taxonomic audit. The Chemical Evolution of Thai Moonseed Family project needs chemical records that can later be joined to phylogenetic data without confusing plant identity, unmeasured activity, and compound absence.
Turn the public PHBV biocomposite proposal into a compact, analysis-ready design specification. The result should expose which observations could support environment-selective degradation and which apparent effects could instead come from sampling, microbial composition, or invalid statistical comparisons. This is design and evidence work; no experimental results exist for this bounty.
Build a traceable comparative evidence dataset that helps Signal Secretome decide what existing experiments do and do not establish about whole mesenchymal stromal-cell secretome versus isolated extracellular vesicles for neuroinflammation. This purchases a bounded analysis of three published studies, not a clinical recommendation or a new experiment.
Build a reproducible endpoint-design calculator from two published RTB101 trials. Quantify how observed event incidence, endpoint composition and baseline-risk uncertainty change the sample size needed for a future randomized trial. This addresses efficacy measurement and planning, separately from adverse-event detection or any claim that mTOR inhibition extends healthy life.
Build a reproducible benchmark comparing simple receptor-signaling models against a mean-only baseline for published mouse head-twitch response magnitude. Test both held-out compounds and transfer between the study's two compound panels. The useful outcome is a bounded decision about what evidence a computational neuropharmacology forecast should require, including a finding that no tested model improves reliably on the baseline.
Build a reproducible shortlist of BCL11A enhancer variants for endogenous functional validation using published saturation-mutagenesis reporter measurements. Quantify how barcode support, multiple testing and effect-size thresholds change the shortlist. A result finding no defensible robust candidates is eligible.
Reanalyze public TAK-925 response curves at OX1R and OX2R to determine when a subtype-selectivity ratio is identifiable and when only a bound or an inconclusive result is justified. Deliver a reproducible quantitative decision aid for interpreting the OX2R-004 program's proposed OX1R counter-screen.
Reanalyze public mouse cecal-metabolite measurements to identify whether early-life-stress-associated differences recur in descendants once cage, litter, experimental batch and multiple comparisons are considered. Deliver reproducible effect estimates and a defensible list of candidates for mechanistic follow-up—or a supported conclusion that none can yet be prioritized.
Build a reproducible target-prioritization sensitivity benchmark from NASA OSD-48's deposited mouse liver differential-expression results. Determine which flight-associated signals are consistent across tissue-handling strata and two published processing outputs, and which should be held for validation before entering a space-resilience target list.
Benchmark the fidelity of three culture conditions to a public freshly isolated mouse tumour-cell reference. Quantify how the culture ranking changes with distance definition and reference-sample uncertainty, then recommend which comparison merits experimental validation for a synthetic tumour-microenvironment program.
Reanalyze public orexin-receptor dose-response data to determine what a cAMP assay can and cannot establish about functional agonism. Produce a reproducible comparison with Gq/IP signaling that helps the OX2R-004 project choose an interpretable functional readout before committing to its proposed assay panel.